Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

Aim. To determine the criteria for the optimal use of IL-6 receptor blockers in patients with COVID-19 community-acquired pneumonia based on predictors of adverse outcomes. Materials and methods. The single-center, non-randomized prospective study included 190 patients with community-acquired pne...

Full description

Bibliographic Details
Main Authors: Tatyana S. Kruglova, Darya S. Fomina, Nataliya G. Poteshkina, Nadija F. Frolova, Irina P. Beloglazova, Zinaida Yu. Mutovina, Inna V. Samsonova, Elena A. Kovalevskaja, Alena I. Zagrebneva, Sofya A. Serdotetckova, Anton A. Chernov, Maryana A. Lysenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2021-11-01
Series:Терапевтический архив
Subjects:
covid-19
interleukin-6
interleukin-6 receptor blockers
tocilizumab
sarilumab
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/99573/73035

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/99573/73035

Similar Items